SL
AHCO icon

Salomon & Ludwin’s AdaptHealth AHCO Stock Holding History

Salomon & Ludwin’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1K Buy
1,591
+604
+61% +$6.18K ﹤0.01% 1123
2025
Q4 		$9.65K Buy
987
+489
+98% +$4.67K ﹤0.01% 1460
2025
Q3 		$4.53K Buy
+498
New +$4.61K ﹤0.01% 1756

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Salomon & Ludwin's AHCO Position: Q1 2026 in Review

Salomon & Ludwin increased its AdaptHealth (AHCO) stake by 61% in Q1 2026, buying an estimated $6.18K and bringing the position to 1,591 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Salomon & Ludwin first reported a position in AHCO in Q3 2025 and has held it in 3 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Salomon & Ludwin held 1,591 shares of AdaptHealth worth $19.1K as of Q1 2026.
  • Salomon & Ludwin bought 604 AdaptHealth shares in Q1 2026, an estimated $6.18K.
  • AdaptHealth made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1123 holding.
  • Salomon & Ludwin first reported a position in AdaptHealth in Q3 2025 and has held it in 3 quarters since.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.